Who is sponsoring NCT05279573?

NCT05279573 is sponsored by Universidad Católica San Antonio de Murcia.

What drugs are being tested in NCT05279573?

Interventions in NCT05279573: Omega-3 and/or botanical ingredient, Control product consumption.

What condition does NCT05279573 study?

NCT05279573 studies Joint Function Disorder.

Is NCT05279573 still recruiting?

NCT05279573 is currently completed. Last updated 28 December 2022.

Last reviewed 2022-12-28 · How we verify

NCT05279573: 7DHA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of a Dietary Ingredient Combination With Omega-3 for Joint Function

Completed NA Last updated 28 December 2022

What this trial tests

NA trial testing Omega-3 and/or botanical ingredient in Joint Function Disorder in 130 participants. Completed in 23 December 2022.

Timeline

14 February 2022

Primary endpoint
29 November 2022

23 December 2022

Quick facts

Lead sponsor	Universidad Católica San Antonio de Murcia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	130
Start date	14 February 2022
Primary completion	29 November 2022
Estimated completion	23 December 2022
Sites	1 location across Spain

Drugs / interventions tested

Omega-3 and/or botanical ingredient
Control product consumption

Conditions studied

Joint Function Disorder — all drugs for Joint Function Disorder →

Sponsor

Universidad Católica San Antonio de Murcia

Who can join

Adults 40 to 75, any sex, with Joint Function Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, controlled, double-blind intervention study of four parallel branches depending on the product consumed, to analyze the efficacy of an Omega-3 based product on the mobility and functionality of the evaluated joint.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of <i>Boswellia serrata</i> Extract and/or an Omega-3-Based Product for Improving Pain and Function in People Older Than 40 Years with Persistent Knee Pain: A Randomized Double-Blind Controlled Clinical Trial.
Pérez-Piñero S, Muñoz-Carrillo JC, Victoria-Montesinos D, García-Muñoz AM, et al · · 2023 · cited 7× · PMID 37686880 · DOI 10.3390/nu15173848

Verify or expand the search:

Other Universidad Católica San Antonio de Murcia trials

Trials by the same sponsor.

NCT07397910 — Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection · NA · not yet recruiting
NCT07519980 — Xanthigen and Its Impact on Weight and Metabolic Health · NA · recruiting
NCT07391189 — Healthy Effects of Adapted Aikido in People With Grip Disfunction · NA · recruiting
NCT07379931 — Evaluating a Liquid Extract of Carob to Improve Blood Sugar in People With Prediabetes · NA · not yet recruiting
NCT07488000 — Plyometric Exercises During the Winter Pre-season in Sprinters · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05279573 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Católica San Antonio de Murcia
Last refreshed: 28 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05279573.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing